# MERILOG

NDC: 0024-5928
Generic name: insulin aspart-szjj
Labeler / Manufacturer: Sanofi-Aventis U.S. LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20250214

FDA application: BLA761325

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0024-5928"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0024-5928
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eee07a52-1102-4d48-9782-26061db175ad